Home / Musculoskeletal system / Zoledronic Acid
ATC M05BA08 · Drugs for Treatment of Bone Diseases
Zoledronic Acid shortage
As of 31 Oct 2026, Zoledronic Acid has a reported shortage in 3 of the 5 countries we track (Italy, Spain, Belgium), covering 7 products.
Countries3/5
Products7packs or presentations
Short since10 Oct 202513 months ago
Earliest return8 Nov 2026company estimate
No return date3products
Main reasonManufacturing problem
Timeline
ItalySpainBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | ACLASTA | SANDOZ PHARMACEUTICALS D.D. | 31 Jul 2026 | not given | Manufacturing problem Problemi produttivi |
| ES | ACIDO ZOLEDRONICO KABI 4MG/5ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 1 vial de 5ml | Fresenius Kabi España, S.A.U. | 2 Jul 2026 | 10 Jan 2027 | Not stated |
| ES | ACIDO ZOLEDRONICO SEACROSS 5 MG/100 ML SOLUCION PARA PERFUSION EFG, 1 vial de 100 ml | Seacross Pharma (Europe) Limited | 6 Oct 2026 | not given | Not stated |
| BE | Aclasta 5 mg/100 ml (Abacus Medicine) inf. sol. i.v. vial 100 ml | Sandoz Pharmaceuticals | 10 Oct 2025 | 31 Dec 2026 | Other Other reason |
| BE | Zoledronate EG 5 mg/100 ml inf. sol. i.v. vial 100 ml | EG | 11 Sep 2026 | not given | Increased demand |
| BE | Aclasta 5 mg/100 ml inf. sol. i.v. vial 100 ml | Sandoz Pharmaceuticals | 20 Sep 2026 | 15 Nov 2026 | Manufacturing problem Delay in production |
| BE | Zoledronic Acid Fresenius Kabi 4 mg/5 ml inf. sol. (conc.) i.v. vial 4 x 5 ml | Fresenius Kabi | 8 Oct 2026 | 8 Nov 2026 | Manufacturing problem Delay in production |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.